Subject: Elevated Levels of Mercury in Faiza No. 1 Beauty Cream - ACTION REQUESTED
Date: 9/28/2017; 10:05:15
Contact Info: Alan L. Talarsky, NJDOH/CEOHS/Public Health and Food Protection Program
Phone: 609-826-4935; Email: firstname.lastname@example.org
Please review the following message from Alan Talarsky, Environmental Scientist 1, Public Health and Food Protection Program, NJDOH regarding the following warning from the New York City Department of Health and Mental Hygiene:
Elevated Levels of Mercury in Faiza No. 1 Beauty Cream
• Faiza No. 1 Beauty Cream, a non-prescription skin-lightening cream available for purchase in New York City, was found to contain dangerously elevated levels of mercury.
• Providers should ask patients about their use of non-prescription skin-lightening creams and advise against using mercury-containing or unlabeled cosmetic products.
• If a patient reports using such products, providers should consider urine testing for mercury in consultation with a medical toxicologist or the New York City Poison Control Center (1-800-222-1222).
Please distribute to all clinical staff in Complementary or Alternative Medicine, Emergency Medicine, Family Medicine, Pediatrics, Gastroenterology, Gynecology & Obstetrics, Internal Medicine, Occupational and Environmental Health, and Primary Care.
The New York City Department of Health and Mental Hygiene (DOHMH) reminds health care providers that some non-prescription skin-lightening creams and soaps can contain toxic levels of inorganic mercury.
In June 2017, DOHMH tested Faiza No. 1 Beauty Cream, a non-prescription topical product available for purchase in New York City. This product, manufactured in Pakistan by A.M. Cosmetics (Pak), claims that it “clears pimples and freckles and makes you white.” Analysis revealed that it contained extremely high levels of mercury, as high as 8,200 ppm – which greatly exceeded the 1 ppm permissible limit set by the U.S. Food and Drug Administration. Many products distributed in New York City are often then distributed in New Jersey, and so this message is being sent in an abundance of caution.
Exposure to mercury can cause serious and life-threatening damage to the central and peripheral nervous system and kidneys. Early inorganic mercury toxicity is typically asymptomatic, but chronic exposure may lead to skin rash, paresthesia, tremors, irritability, memory loss and depression. Renal effects include proteinuria, acute tubular necrosis and nephrotic syndrome.
Health care providers should ask patients about their use of non-prescription, topical skin-lightening products and counsel patients against using cosmetic products that list mercury as an ingredient or that do not include a list of ingredients on the label. If a patient reports using such products, providers should consider urine testing for mercury. Initial testing should include a spot urine mercury concentration followed by a 24-hour urine mercury level. Blood testing is of limited value for inorganic mercury exposure.
Resources for health care providers on mercury poisoning can be found here:
At this time, the Public Health and Food Protection Program is recommending that local health department officials, during the course of routine inspections, verify that the above products are not remaining in retail establishments' shelves nor offered for sale in any other establishments where cosmetics are sold. If any developments or requests for assistance from NYC DOHMH are received, then PHFPP will promptly notify you.
This information has been distributed to: DOH Senior Staff; DOH Staff; LINCS Health Officers; LINCS Health Officer Assistants; LINCS Coordinators; LINCS Coordinator Backups; LINCS Epidemiologists; LINCS Health Educators; LINCS Health Planners; LINCS IT Specialists; LINCS Partnership Coordinators; LINCS Public Health Nurses; LINCS Regional Health Planners; LINCS Team Members; LINCS CD Investigators; LINCS REHS; LOCAL Health Officers; LOCAL Public Health; LOCAL CD Investigators; LOCAL Health Educators; LOCAL Public Health Nurses; LOCAL REHS; LOCAL Epidemiologists; Medical Coordination Center Staff
Further distribution of this message should be directed to: n/a
IMPORTANT NOTE: Please do not use reply feature of your email system. If you have questions about the content of this email or any of its attachments, please call your County/City LINCS agency for assistance. LINCS agencies are instructed to contact the individual listed in message above or on the attachment for questions concerning content.